Association between Circulating MicroRNAs (miR-21-5p, miR-20a-5p, miR-29b-3p, miR-126-3p and miR-101-3p) and Chronic Allograft Dysfunction in Renal Transplant Recipients
Open Access
- 14 October 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (20) , 12253
Abstract
Chronic allograft dysfunction (CAD) is a major condition affecting long-term kidney graft survival. Serum microRNA (miRNA) has been reported as a biomarker for various conditions of allograft injuries. The upregulation of miR-21 is the best-known miRNA change in graft tissue, urine and plasma. However, the correlation of plasma miR-21 with the severity of CAD remains unclear. In our study, 40 kidney transplantation recipients with late graft survival for more than 10 years were enrolled. The CAD group (n = 20) had either an eGFR between 15 to 60 mL/min or a biopsy-proved chronic allograft nephropathy or rejection. The control group (n = 20) had an eGFR ≥ 60 mL/min without proteinuria and hematuria for a consecutive 3 months before the study. We performed RNA sequencing to profile the miRNAs expression. There were six differentially expressed miRNAs in the CAD group. Among them, miR-21-5p and miR-101-3p were decreased, and miR-20a-5p was increased. We found that miR-21-5p, miR-20a-5p and miR-101-3p all participated in the TGF-beta pathway. We demonstrated that decreased miR-21-5p and miR-101-3p, and increased miR-20a-5p were the novel CAD-associated miRNAs in the TGF-beta pathway. These findings may pave the way for developing early prediction miRNAs biomarkers for CAD, and possibly developing therapeutic tools in the field of kidney transplantation.Keywords
Funding Information
- Taichung Veterans General Hospital (TCVGH-1113603C)
- Taichung Veterans General Hospital Chia-Yi Branch (TCVGH-VHCY1118602)
This publication has 62 references indexed in Scilit:
- TGF-β: the master regulator of fibrosisNature Reviews Nephrology, 2016
- Increased Circulating miR-21 Levels Are Associated with Kidney FibrosisPLOS ONE, 2013
- MicroRNA Sequence Profiles of Human Kidney Allografts With or Without Tubulointerstitial FibrosisTransplantation, 2012
- MicroRNAs, transforming growth factor beta‐1, and tissue fibrosisThe Journal of Pathology, 2012
- Urinary miR-21, miR-29, and miR-93: Novel Biomarkers of FibrosisAmerican Journal of Nephrology, 2012
- Suppression of microRNA-29 Expression by TGF-β1 Promotes Collagen Expression and Renal FibrosisJournal of the American Society of Nephrology, 2012
- Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitroKidney International, 2012
- TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29Journal of the American Society of Nephrology, 2011
- Identification of a microRNA signature of renal ischemia reperfusion injuryProceedings of the National Academy of Sciences, 2010
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosisProceedings of the National Academy of Sciences, 2008